1306763-30-3

Basic information

• Product Name: (S)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate
• Synonyms: (S)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate;Ozanimod intermediate 1;TERT-BUTYL N-[(1R)-4-CYANO-2,3-DIHYDRO-1H-INDEN-1-YL]CARBAMATE
• CAS NO: 1306763-30-3
• Molecular Formula: C₁₅H₁₈N₂O₂
• Molecular Weight: 258.31562
• EINECS: -0
• Mol File: 1306763-30-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 411.9±44.0 °C(Predicted)
• Appearance: /
• Density: 1.15±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 11.86±0.20(Predicted)
• CAS DataBase Reference: (S)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate(1306763-30-3)
• EPA Substance Registry System: (S)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate(1306763-30-3)

Safety Data

• Hazardous Substances Data: 1306763-30-3(Hazardous Substances Data)

Usage

Uses

(R)-tert-Butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate is a useful reagent in the preparation of oxadiazoles as sphingosine 1 phosphate receptor modulators useful in the treatment of S1P1-associated diseases.

Upstream product

• 1306763-28-9 (R)-N-((R)-4-cyano-2,3-dihydro-1H-inden-1-yl)-2-methylpropane-2-sulfinamide 
• 1306763-27-8 (R)-N-(4-cyano-2,3-dihydro-1H-indene-1-ylidene)-2-methylpropane-2-sulfinamide 
• 15115-60-3 4-bromo-2,3-dihydroinden-1-one 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1306763-29-0 (R)-(1-amino-2,3-dihydro-1H-indene-1-yl)-4-carbonitrile hydrochloride 
• 60899-34-5 4-cyano-2,3-dihydro-1H-inden-1-one 

Downstream Products

• 1306763-41-6 (R)-tert-butyl 2-(tert-butyldimethylsilyloxy)ethyl(4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate 
• 1307231-06-6 (R)-tert-butyl 4-(5-(3,4-diethoxybenzyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate 
• 1306763-42-7 (R)-tert-butyl 2-(tert-butyldimethylsilyloxy)ethyl(4-(N-hydroxycarbamimidoyl)-2,3-dihydro-1H-inden-1-yl)carbamate 
• 1307231-07-7 (R)-tert-butyl 2-(tert-butyldimethylsilyloxy)ethyl(4-(5-(4-phenyl-5-(trifluoromethyl)thiophen-2-yl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)carbamate 
• 1307231-27-1 (R)-tert-butyl (2-((tert-butyldimethylsilyl)oxy)ethyl)(4-(N-((4-phenyl-5-(trifluoromethyl)thiophene-2-carbonyl)oxy)carbamimidoyl)-2,3-dihydro-1H-inden-1-yl)carbamate 
• 1306763-71-2 (R)-tert-butyl 4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate 
• 1306760-86-0 (R)-5-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile 

Relevant articles and documents

COMPOUNDS AND METHODS FOR TREATING LUPUS

Methods for treatment of systemic lupus erythematosus (SLE" or "Lupus") by administration of a modulator of sphingosine-1-phosphate receptor subtype 1 (S1P1), as well as compositions and methods related to the same, wherein such S1P1 modulators have the f

SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS

Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.